U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The order instructs the attorney general to move quickly toward reclassifying marijuana under the Controlled Substances Act, potentially shifting it from Schedule I to Schedule III.
If reclassified, marijuana would be grouped with drugs such as certain painkillers, ketamine, and testosterone, which are considered to have accepted medical uses and lower abuse potential. While marijuana would remain illegal at the federal level, the change could dramatically reshape the cannabis industry by expanding medical research opportunities, improving access to funding, and easing barriers for banks and institutional investors.
Trump defended the decision by emphasizing patient needs, saying many Americans suffering from chronic pain have pushed for greater access to marijuana-based treatments. Although he reiterated that he does not personally use the drug and remains cautious about controlled substances, he acknowledged its growing demand and medical relevance.
The move drew mixed reactions in Washington. Senate Democratic Leader Chuck Schumer welcomed the order, calling it a step toward long-overdue reform. In contrast, dozens of Republican lawmakers urged Trump not to proceed, arguing that reclassification could send the wrong message to children, empower drug cartels, and increase safety risks on U.S. roads.
Industry experts noted that congressional action would still be required to establish stable nationwide cannabis regulations. The Drug Enforcement Administration must now review the recommendation, a process that has historically been slowed by bureaucracy. Even with reclassification, marijuana would still face federal restrictions and criminal penalties.
Cannabis stocks initially rose on the news but later fell as investors realized the order did not include provisions for cannabis banking reform. Limited access to traditional financing remains a major challenge for marijuana companies, contributing to high operating costs and the persistence of black-market activity.
Public opinion continues to favor legalization, with most Americans supporting broader reform. Combined with previous efforts, including reviews initiated under former President Joe Biden, Trump’s order signals a continued shift toward easing long-standing federal marijuana policies while leaving the final outcome uncertain.


U.S. Senators Move Toward Deal to Strengthen Military Helicopter Safety Rules
Sydney Bondi Beach Terror Attack Kills 16, Sparks Gun Law and Security Debate
Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
Fernando Haddad Confirms He Will Not Run for Office in 2025, Signals Possible Exit as Brazil’s Finance Minister
Trump Administration Plans Major Increase in Denaturalization Cases for Naturalized U.S. Citizens
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
EU Expands Carbon Border Levy to Car Parts and Appliances, Tightening Climate Trade Rules
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
U.S. Homeland Security Ends TSA Union Contract, Prompting Legal Challenge
Australia Pushes Forward on AUKUS Submarine Program Amid Workforce and Production Challenges
Pakistan’s Army Chief Faces Gaza Troop Dilemma Amid US Pressure
Trump Signals Progress in Ukraine Peace Talks Ahead of U.S.–Russia Meeting 



